This inventor holds 3 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Zeneca Limited, Other. Active years: 1995-2005.
Location History:
- Kiel, DE (1995)
- 2300 Kiel 1, DE (2001 - 2005)
Company Filing History:
1 out of 854 
2 out of 834,411 Years Active: 1995-2005
Title: Oliver Wiedow: Innovator in Nucleic Acids and Polypeptides
Introduction
Oliver Wiedow is a notable inventor based in Kiel, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acids and polypeptides. With a total of 3 patents to his name, Wiedow's work has implications for medical research and therapeutic applications.
Latest Patents
Wiedow's latest patents include innovative findings related to nucleic acids and polypeptides. One of his key patents focuses on a polypeptide of formula I and its analogues, which possess inhibitory activity against human leukocyte elastase. These polypeptides can be obtained through expression using plasmidic expression systems in hosts such as yeast. Additionally, the polypeptide of formula I can also be derived from psoriatic plaques, showcasing its potential in addressing specific medical conditions.
Career Highlights
Throughout his career, Oliver Wiedow has worked with various organizations, including Zeneca Limited. His expertise in biotechnology has allowed him to contribute to advancements in the field, particularly in the development of therapeutic agents derived from polypeptides.
Collaborations
Wiedow has collaborated with notable professionals in his field, including Jens-Michael Schroder and Enno Christophers. These collaborations have further enriched his research and innovation efforts.
Conclusion
Oliver Wiedow stands out as an influential inventor in the realm of biotechnology, with a focus on nucleic acids and polypeptides. His contributions continue to pave the way for advancements in medical research and therapeutic solutions.